Literature DB >> 1839809

Modulation by serotonin of glutamate-induced lethality in mice.

J Kamei1, H Igarashi, Y Kasuya.   

Abstract

To determine the involvement of serotonergic mechanisms in glutamate-induced excitotoxicity, the effects on glutamate-induced lethality of drugs that modify serotonergic transmission were studied in mice. Monosodium glutamate (MSG; 6-10 g/kg, i.p.) produced a dose-related increase in lethality in mice. Pretreatment with reserpine (2.5 mg/kg, i.p., 5 hr) resulted in an increase in MSG-induced lethality. p-Chlorophenylalanine (PCPA; 300 mg/kg, i.p. 24 hr) specifically produced a reduction of more than 60% in the level of 5-HT in the brain. PCPA-treated mice were also more sensitive to the lethal effects of MSG. alpha-Methyl-p-tyrosine (300 mg/kg, i.p. 5 hr) produced a significant reduction in the levels of norepinephrine and dopamine in the brain, but the sensitivity to the lethal effects of MSG was unchanged. L-Tryptophan (300 and 500 mg/kg, i.p.) and 5-hydroxy-L-tryptophan (5-HTP; 3-30 mg/kg, i.p.), precursors of serotonin (5-HT), protected mice to a significant extent against MSG-induced lethality, in a dose-related manner. 1-(m-Trifluoromethylphenyl) piperazine (TFMPP; 50 mg/kg, i.p.), an agonist of 5-HT1 receptor, was also associated with protection against MSG-induced lethality. This protective effect was not observed in PCPA- or methysergide-treated mice. These results suggested that 5-HT in the brain may play an inhibitory role in MSG-induced excitotoxicity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1839809

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  3 in total

1.  5-Hydroxy-2-(2-phenylethyl)chromone (5-HPEC): a novel non-nitrogenous ligand for 5-HT2B receptor.

Authors:  Dwight A Williams; Saheem A Zaidi; Yan Zhang
Journal:  Bioorg Med Chem Lett       Date:  2014-02-19       Impact factor: 2.823

2.  Presaturation Power Adjusted Pulsed CEST: A Method to Increase Independence of Target CEST Signals.

Authors:  Kazufumi Kikuchi; Keisuke Ishimatsu; Shanrong Zhang; Ivan E Dimitrov; Hiroshi Honda; A Dean Sherry; Masaya Takahashi
Journal:  Contrast Media Mol Imaging       Date:  2018-05-08       Impact factor: 3.161

3.  Estimating the causal effects of modifiable, non-genetic factors on Huntington disease progression using propensity score weighting.

Authors:  Beth Ann Griffin; Marika Suttorp Booth; Monica Busse; Edward J Wild; Claude Setodji; John H Warner; Cristina Sampaio; Amrita Mohan
Journal:  Parkinsonism Relat Disord       Date:  2021-01-13       Impact factor: 4.891

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.